To investigate whether the ADAM17 substrates Nectin-4, HB-EGF and AREG could potentially be used as diagnostic tumor markers for ovarian cancer, a cohort of 131 patients with primary ovarian cancer was assembled and characterized with respect to their clinicopathologic parameters. Here, AREG is linked to ovarian cancer.